Covid-19 Medicine found by Turkish Professor

[gültekin]

Turkish scientist professor who discovered the medicine of the corona DR. İbrahim Benter gave the good news
https://www.haber7.com/guncel/haber/...verdi/?detay=2
https://newsbeezer.com/turkeyeng/tur...the-good-news/

Turkish scientists living in Germany about the coronavirus vaccine Prof. DR. The discovery of Uğur Şahin and Özlem Türeci gave the whole world great hope. After the studies that gained the world recognition for the vaccine, another piece of good news came from the coronavirus drug.

FIRST CORONA MEDICINAL PRODUCTS MANUFACTURED

Turkish scientists first found the vaccine, then developed a test and have now found the corona drug. In this context, Prof. DR. The Formycon company produced the first corona drug with the work of İbrahim Benter.

“COVID-1
9 HAS BEEN TREATED”

In conversation with Kanal D Haber about the drug, Prof. DR. İbrahim Benter, “The treatment for covid-19 has been found.” made the explanation.

Benter used the following statements throughout the rest of his speech: “This drug will be able to treat the sick, meaning people who have received this vaccine or who have not received this vaccine will be able to prevent the damage to the virus in the body from using this drug. This drug will be great in the short and long term be effective. “

“It will end the drug pandemic”

“Even if the virus mutates and changes and becomes resistant to vaccines, we can use this approach to cure these diseases. It is more possible to say something about its side effects and doses, but we hope this is a drug which has other benefits without major side effects. Corona treatment has been found. ” I believe this will now bring the end of the pandemic.

“DRUG CLOSES THE DOORS OF CORONAVIRUS”

The drug developed completely prevents cells from becoming infected with this virus and uses the ACE2 receptors that allow the virus to enter the body. The drug works exactly where the ACE2 antibody fusion protein, which effectively binds to coronaviruses, comes from. In a way, it closes the coronavirus arrival doors. It has been announced that the drug will also be effective against the mutated version of the virus. Carsten Brockmeyer, CEO of Formycon, said in a statement that people who are now in the hospital have a different treatment option.

“FUTURE CORONAVIRUS OUTBREAKS WILL BE PREVENTED THIS WAY.”

Brockmeyer explained that the drug is the solution at this point: “Antibodies target very specific regions on the surface of the SARS-CoV-2 virus. However, a small mutation in the virus is enough to inactivate them. With this drug we block the entrance gate through which the virus enters cells. “It also offers maximum protection against mutations. Future coronavirus outbreaks will be prevented this way, “he said.

Early date 2022

The company that developed the drug announced that it has reached out to the US Drug Approval Center and the European Union Approval Center and that the rapid approval process has been carried out. However, even the fastest approval suggests the drug won’t be able to hit the market until early 2022.

WHO IS İBRAHİM BENTER?

Prof. Prof. DR. İbrahim F. Benter was born in Nicosia in 1962. Studying at the Turkish Maarif College, Prof. DR. İbrahim Benter was in the USA between 1980 and 2000. He graduated from Florida University School of Chemistry in 1985. He graduated from the New York School of Medicine and received his PhD from the Ohio State University School of Medicine in 1991. The Cleveland Clinic Foundation also specializes in the brain and vascular department. As a researcher in the Department of Hypertension Research at the Wake Forest University Medical School, Prof. DR. İbrahim Benter worked in 1994, first as an assistant professor and then as an associate professor at the University of Tennessee Medical School and the Memphis Eye School.

He has received many awards in education and research. Its main invention, a hormone called angiotensin (1-7), is being tested for cancer, high blood pressure, and heart disease. From 2001 to 2012 he worked as a professor in the Department of Pharmacology of the Medical Faculty of Kuwait University, as Head of Department and in many administrative offices. He has been with Oxford University since September 2012. He worked with Nobel Laureate Professor Sir John Vane and Professor Sir Martin Evans. The research topic is the treatment of heart and vascular problems in high blood pressure and diabetes patients.

[Altaylı]